Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

The Women in Pharma Awards 2026 has unveiled its shortlist, marking a significant milestone in Ireland's pharmaceutical calendar. In its second year, the programme has established itself as the country's premier platform for honouring women's contributions to excellence, innovation, and leadership across the life sciences. Categories span the full spectrum of the industry, from Best Female Led Team and Excellence in Senior Leadership across pharma, life sciences, and contract services to Rising Star of the Year and Workplace of the Year, reflecting the breadth of achievement driving sector progress. The awards also include specialised categories for leadership in clinical operations, education and mentoring, supply chain and logistics, engineering and manufacturing, finance, HR, marketing and communications, quality, sales and commercial, and site leadership, alongside two special honours: the Overall Leader Award and the Legacy Award, which will both be announced at the ceremony.

Author: Archie Villaflores

Asahi Kasei will acquire biopharmaceutical company Aicuris for approximately €780 million ($919 million). The transaction expands Asahi Kasei's pharmaceutical manufacturing excellence platform into severe infectious diseases for immunocompromised patients.

Author: Archie Villaflores

Eton Pharmaceuticals has acquired commercialisation rights to HEMANGEOL oral solution for infantile hemangioma treatment. The transaction expands Eton's rare disease portfolio to ten commercial products and strengthens pharmaceutical manufacturing excellence capabilities.

Author: Archie Villaflores

Zymeworks has secured $250 million (€212 million) in royalty-backed financing from Royalty Pharma to strengthen its balance sheet. The transaction supports pharmaceutical manufacturing excellence operations and provides capital for strategic acquisitions through 2028.

Author: Archie Villaflores

Novo Nordisk has submitted a full reimbursement application to Ireland's Health Service Executive for obesity drug Wegovy. The assessment process strengthens pharmaceutical manufacturing excellence sector engagement with national healthcare systems and patient access frameworks.

Author: Archie Villaflores

County Galway-based Chanelle Pharma reported pretax profits increasing 51.5 per cent to €16.75 million as revenues rose 17 per cent to €223.19 million. The performance strengthens Ireland's position in generic pharmaceutical manufacturing excellence.

Author: Archie Villaflores

Danish pharmaceutical manufacturer Novo Nordisk will invest €430 million to expand its Athlone facility for tablet production of weight loss drug Wegovy. The development strengthens Ireland's pharmaceutical manufacturing excellence capabilities and creates 600 construction positions.

Author: Archie Villaflores

Strategic partnerships that unlock AI-driven discovery and acquisitions that consolidate cell therapy manufacturing drive pharmaceutical sector growth. Companies securing investment whilst acquiring clinical-stage assets demonstrate how capital deployment accelerates therapeutic development and market entry. Turning the clock back to last year's accomplishments, 'Uniphar Medtech wins Corporate Social Responsibility Programme of the Year at Pharma Industry Awards 2025' earned recognition for its Local Competitive Advantage initiative transforming local inclusion into a talent pipeline. This achievement establishes benchmarks for the 2026 awards, where strategic social investment aligned with business objectives will distinguish CSR leadership. Furthermore, 'Belfast drug discovery firm secures South Korean strategic investment' demonstrates how AI-enabled platforms attract international biotech backing through multi-omic data mining and oncology programme validation. AMPLY Discovery's partnership with Keeps Biomed strengthens Northern Ireland's pharmaceutical research capabilities whilst exploring collaboration opportunities. Meanwhile, 'Gilead Sciences acquires CAR-T specialist Arcellx for $7.8 billion' reflects how pharmaceutical majors consolidate cell therapy manufacturing through strategic acquisition of companies approaching regulatory approval. The transaction adds anito-cel to Gilead's blood cancer portfolio with FDA action anticipated by December 2026. Investment and acquisition define pharmaceutical sector momentum. Read each story to understand how strategic partnerships and manufacturing consolidation are accelerating therapeutic development.

Author: Jed Nykolle Harme

Honoured for transformative community impact in 2025, Uniphar Medtech won Corporate Social Responsibility Programme of the Year at the Pharma Industry Awards 2025, setting a benchmark for talent development as the sector looks toward 2026.

Author: Archie Villaflores

United States pharmaceutical manufacturer AbbVie will invest $380 million (€322 million) to construct two manufacturing facilities at its North Chicago campus. The plants will produce active pharmaceutical ingredients for obesity and neuroscience medications, creating 300 positions.